NCT00018174View on ClinicalTrials.gov

Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2005

Conditions
DepressionSmoking
Interventions
DRUG

Fluoxetine

BEHAVIORAL

Behavioral group smoking cessation treatment

DRUG

Placebo

Trial Locations (1)

60141-3030

Edward Hines, Jr. VA Hospital, Hines

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

US Department of Veterans Affairs

FED

NCT00018174 - Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers | Biotech Hunter | Biotech Hunter